Conference
Effectiveness of first-line immune checkpoint inhibitors (ICI) in advanced non-clear cell renal cell carcinoma (ccRCC).
Abstract
316
Background: Immune checkpoint inhibitors (ICI) have demonstrated impressive activity in metastatic clear-cell renal cell carcinoma (ccRCC) and have become standard treatment options in this setting. Data supporting the effectiveness of ICI based therapy in non-clear cell RCC (nccRCC) is more limited. Methods: We performed a retrospective analysis using the International Metastatic RCC Database Consortium (IMDC). Patients …
Authors
Graham J; Wells C; Dudani S; Gan CL; Donskov F; Lee J-L; Kollmannsberger CK; Pal SK; Beuselinck B; Hansen AR
Volume
39
Pagination
pp. 316-316
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 20, 2021
DOI
10.1200/jco.2021.39.6_suppl.316
Conference proceedings
Journal of Clinical Oncology
Issue
6_suppl
ISSN
0732-183X